Aditya R Das is a notable inventor based in Foster City, CA (US), recognized for his contributions to pharmaceutical delivery systems. He holds 4 patents that focus on innovative methods for administering medications effectively. His work primarily addresses critical health issues, including agitation in psychiatric disorders and treatment for Parkinson's disease.

Latest Patents

One of his latest patents involves the intranasal delivery of olanzapine using a precision olfactory device. This method is designed for the acute treatment of agitation, particularly in patients with schizophrenia or bipolar disorder. The patent outlines a dry pharmaceutical composition that, when administered intranasally, achieves a mean peak plasma olanzapine concentration of at least 30 ng/mL within less than 0.5 hours. Another significant patent focuses on the respiratory tract delivery of levodopa and a dopa decarboxylase inhibitor for treating Parkinson's disease. This dry pharmaceutical composition includes levodopa, a DDI, and excipients, providing a method for effectively treating patients with Parkinson's disease or Parkinson syndrome.

Career Highlights

Aditya has worked with prominent companies in the pharmaceutical industry, including Impel Pharmaceuticals Inc. and Impel Neuropharma, Inc. His experience in these organizations has contributed to his expertise in developing innovative drug delivery systems.

Collaborations

Throughout his career, Aditya has collaborated with talented individuals such as John D Hoekman and Kelsey H Satterly. These partnerships have enhanced his research and development efforts in the field of pharmaceutical innovations.

Conclusion

Aditya R Das stands out as an influential inventor in the realm of pharmaceutical delivery systems. His innovative patents and collaborations reflect his commitment to improving patient care through advanced medication administration techniques.

This text is generated by artificial intelligence and may not be accurate.